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Abstract 
The second half of the twenties
  century saw a sharp worldwide decline in the both 
incidence and mortality of gastric cancer. Despite this the condition remains the world’s 
second leading cause of cancer mortality, second only to lung cancer. Although most 
gastric cancers arise in the antrum and body (non-cardia) of the stomach, the incidence of 
proximal tumours of the cardia and distal oesophagus have increased dramatically over the 
last fifty years throughout the world. This major change in the pattern of the disease 
suggests that gastric cancer (cardia versus non-cardia) is not one but two separate disorders 
with regard to cause and pathogenesis. Over the last fifty years there has been concern 
about luminal nitrite, derived from dietary nitrate, as a risk factor for upper gastro-
intestinal malignancies. This has arisen from evidence that the salivary nitrite is rapidly 
converted to nitrosating species and (in the presence of ascorbic acid) nitric oxide (NO), 
which are both potentially mutagenics.  
Thus this  study aimed  to investigate the influence of ascorbic acid (AA), sodium 
thiocyanate (NaSCN), oxygen (O2) and pH (1.5, 2.5 and 3.0) on the nitrite chemistry in 
simulated gastric juice. Another aim of the present study was to investigate the influence of 
a range of water-soluble dietary phenolics antioxidants on the nitrite chemistry to compare 
their effect with that of ascorbic acid. The capacity of dietary phenolics and ascorbic acid 
to reduce the acidified nitrite to nitric oxide was also investigated under both aerobic and 
anaerobic conditions. 
These studies were performed in a newly designed closed bench-top model reproducing the 
chemical environment occurring at the human gastro-oesophageal junction. Each of the 
experiments was performed with and without NaSCN at different pH values (1.5, 2.5 and 
3.0) under both aerobic and anaerobic conditions. The studies were focused on the 
measurement of NO formation and O2  consumption by electrochemical detection, 3 
according to the antioxidant present in the system (ascorbic acid, ferulic acid, caffeic acid, 
gallic acid or chlorogenic acid, in a range of concentrations).  
Nitric oxide production increased with increasing ascorbic acid concentration, and was 
greatest at the lowest pH of 1.5. The absence of oxygen in the system markedly increased 
nitric oxide levels in the presence of ascorbic acid, while the addition of NaSCN enhanced 
nitric oxide production and oxygen consumption. A different pattern of nitric oxide 
production was seen with the dietary phenolics compared with ascorbic acid. In addition, 
two different patterns of nitric oxide response were seen with ferulic acid and caffeic acid 
and another with gallic acid and chlorogenic acid. Ferulic and caffeic acids produced only 
a small initial increase in nitric oxide, which was not sustained under either aerobic or 
anaerobic conditions. In contrast, gallic and chlorogenic acids produced a much more 
marked rise in nitric oxide, which remained elevated under both aerobic and anaerobic 
conditions. The only phenolic experiment in which an equivalent concentration of nitric 
oxide to that with ascorbic acid was observed was with high concentration of gallic acid 
under anaerobic conditions. 
These studies indicated that nitrite in the simulated GOJ environment is converted to 
varying extents to nitric oxide and factors influencing this include luminal pH, thiocyanate, 
oxygen tension and presence of antioxidants. We have also found that the capacity of 
antioxidants to convert acidified nitrite to nitric oxide varies as does the temporal profile of 
the nitric oxide concentration generated by them. 
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Chapter 1 - Introduction Chapter 1    19 
1.1  Anatomy and physiology of stomach 
The stomach is a J-shaped muscular bag located in the left upper part of the abdominal 
cavity mainly in the left hypochondrial, epigastric and umbilical regions, which has two 
openings: the cardia and the pylorus 
(1-3). These openings join the stomach with the 
oesophagus proximally and with the duodenum distally to form the gastro-oesophageal 
junction and gastro-duodenal junction respectively (Figure 1.1A). The former lies 2.5 cm 
to the left of mid line at the level of T 10 vertebra, and the latter lies to the right of mid line 
at the level of L 1vertebra
 (1-3). 
The stomach is completely invested by peritoneum to form the lesser and greater omenta 
that contain the vascular and lymphatic supply
 (3).  
 
Figure 1.1:Anatomy and histology of the stomach is described the stomach and its subdivision (A), cut 
section shows the muscular layers and internal anatomy (B) and stomach wall histology (C) 
(4). 
 Chapter 1    20 
The stomach has four anatomically distinct areas, each containing different types of 
histological cell. The cardia,  distal to the gastro-oesophageal junction (GOJ), 
predominantly consists of simple tubular glands lined by mucus secreting cells, numerous 
endocrine cells, and a few acid secreting cells 
(1, 5-7). The fundus is the uppermost part of 
the stomach, occupying the area above the opening of oesophagus into the stomach (above 
the gastro-oesophageal junction). The body is the largest part of the stomach, representing 
about two third of gastric area. The glands of the fundus and body consist of a range of 
secretary cells:    
- parietal cells  mainly in the upper part of the gland, which in addition to acid also 
produces intrinsic factor and blood group substances;    
- chief cells  mostly located in the lower part of gland,  which are the main source of 
pepsinogen and proteolytic enzymes. In addition to these cells the body mucosa also 
contains some mucus neck cells and endocrine cells, the latter producing histamine in 
response to gastrin 
(1, 5-7).  
The pyloric antrum represents the lower third of the stomach and has a funnel shaped 
appearance. Its wide part connects to the stomach whereas the narrowing portion connects 
the stomach with the pyloric canal. The gland of the pylorus consists of cell secreting 
mucus and gastrin hormone and occasionally parietal cells 
(1, 5-7).  
The stomach wall is composed of four different layers, which are arranged from inside to 
outside. These are the mucosa, sub mucosa, muscularis layer, and serosa (Figure 1.1C). 
The stomach mucosa is an entirely tubular glandular form, with a variety of secretary cells, 
these cells differ from one to another anatomical sub-division described before. In general, 
the gastric mucosa has two components - the surface epithelium and its pits (foveolae) and 
the glandular structure. The surface epithelium and the pits appear throughout the stomach 
wall and are lined by mucus-secreting columnar cells which also secrete bicarbonate and 
sodium ions. The glandular component differs in the thickness and type of the cells from Chapter 1    21 
one region to another. For example, the foveolae zone of cardiac and pyloric is the half 
thickness of the mucosa, while the glandular component in the fundus and body is much 
thicker than the foveolar zone 
(5-8).  
The stomach sub mucosa is composed entirely of a thick sheet of connective tissue, which 
provides elasticity to the stomach. It contains many vascular and lymphatic vessels as well 
as sub mucosal nerve plexus 
(6-8). In addition to the standard pattern of wall structure which 
is present throughout the digestive tract, longitudinal and circular muscle layers, the 
stomach wall has a third layer of oblique muscles, or muscular layer
 (5-8). The serosa is the 
outer layer of the stomach wall and consists of supporting connective tissue, the inner layer 
of fibrous tissue provides structural support while the epithelial tissue “mesothelium”, 
secrets a watery lubricant fluid 
(6-8). 
1.2  Stomach pathologies 
The stomach, like any other organ in the body, can experience both benign and malignant 
tumours. Adenocarcinoma are much more common than any other malignant tumours 
(such as carinoid tumours, malignant stromal tumours and lymphoma) or benign tumours 
(8-10).  
Adenocarcinoma have been divided histologically into two main types; the diffuse and 
intestinal types 
(11). The diffuse type adenocarcinoma consists of sheets of neoplastic cells 
with minimal gland formation which leads to a significant thickening of the gastric wall. 
The development of the diffuse cancer is correlated with genetic factors, is more common 
in the younger population, and has a male to female ratio of 1:1. Unfortunately this type of 
adenocarcinoma carries a bad prognosis and survival rate is lower than the intestinal type 
tumours 
(8-12) (Figure 1.2A).  Chapter 1    22 
Intestinal type adenocarcinoma, on the other hand, shows glandular formation similar to 
that of colonic adenocarcinoma. This intestinal sub-type of adenocarcinoma is also 
associated with the presence of metaplastic intestinal epithelium, tends to be more common 
in countries presenting high-incidence of gastric cancer, and significantly correlates with 
environmental factors such as H. pylori-associated chronic gastritis. Furthermore, the 
intestinal type is more common in males than females; with a ratio of 2:1, and the mean 
age of patients is 55 years 
(8-12). However, some tumours show features of both types and 
are more difficult to categorise 
(11) (Figure 1.2B). 
Recently, gastric cancer has been sub-classified according to the intra- gastric anatomical 
site. It either arises from the proximal region of the stomach (cardia) or more distal part 
(non cardia) 
(13-15). Most gastric cancer arises in the antrum and body (non cardia) of the 
stomach, however, the incidence of proximal tumours of the cardia and the gastro-
oesophageal junction has increased dramatically over the last 25 years 
(16-18).  
These changes in the pattern of stomach malignancies throughout the world is not merely 
to be related to changes in tumour classification, change in diagnostic methods or an 
increased general awareness of this disease aetiology and epidemiology 
(14, 19). It is possible 
to conclude that gastric cancer (cardia versus non-cardia) is not one but two separate 
disorders with regard to cause and pathogenesis 
(14). Chapter 1    23 
(A) 
 
 
 
 
 
(B) 
 
Figure 1.2: Histological classification of gastric adenocarcinoma, the diffuse type (A), and intestinal 
type (B) 
(20) . Chapter 1    24 
1.3  Gastric and oesophageal adenocarcinoma 
1.3.1  Epidemiology 
In spite of a steady decline in the overall incidence of gastric cancer, observed in most 
countries in the last decades, incidences of cardia cancer have increased in recent years 
(16-
18, 21).
  Meanwhile, the overall incidence of oesophageal cancer (including oesophageal 
squamous cell carcinoma) has decreased throughout the last thirty years; while 
adenocarcinoma of the distal oesophagus has increased dramatically in most Western 
countries as well as in some other countries over the worlds 
(16-18, 21). Thus gastric cancer 
and oesophageal cancers still remain the second and the sixth leading cause of cancer-
related death, respectively 
(19, 22) (Figure 1.3A and B).  
Gastric and oesophageal adenocarcinoma, similar to most other GI malignancies, are the 
diseases of older age groups in most countries. The mean age at diagnosis is 63 years and 
the risk increases with increasing age 
(19, 22). The diseases predominantly affect men and 
white patients twice as often as black patients 
(14, 19, 23). Furthermore, in relation to sub-site 
distribution, Roder (2002) states that the percentage of gastric cancers sited in the cardia, 
as opposed to more distal specified sub site, was 31.7 % for males and 18.8 % for females, 
with higher percentages applying to male than females in each region 
(24).  
The geographical variation of oesophagus and cardia adenocarcinoma differs between 
countries. In developed countries, the incidence of distal stomach cancer has decreased, 
while stomach cancer in the most proximal cardia region and GOJ has increased 
substantially. According to a review of literature, the highest incidence has been reported 
in the United Kingdom, Australia, and United States. However, low incidence has also 
been reported in Eastern Europe and Scandinavia 
(14, 19). Chapter 1    25 
 
(A) 
 
(B) 
 
 
Figure 1.3: Age- standardised incidence of adenocarcinoma of oesophagus (A) and gastric cardia (B) 
cancer Solid black line adenocarcinoma in male; dashed line adenocarcinoma in female 
(18). Chapter 1    26 
1.3.2  Aetiology  
The reasons for the sharp increase in the incidence of adenocarcinoma of the oesophagus 
and the gastric cardia over the past fifty years are still unknown. However, one explanation 
for these similar trends may be that the adenocarcinoma of the oesophagus and the gastric 
cardia share at least some aetiological factors 
(18, 25-27).  
Cancer of the oesophagus and gastric cardia differs from cancer of the more distal stomach 
(21, 28-31) (Figure 1.4). The cancer of the distal stomach develops against a background of 
atrophic gastritis and hypochlorhydria, usually due to H. pylori infection and is more 
common amongst those from lower socioeconomic classes 
(29, 31). In contrast, the cancer of 
GOJ and cardia occurs in patients with healthy acid secreting mucosa, normal secretary 
function, who are usually H. Pylori negative, and are more in the professional social class 
population 
(21, 28-31).  
Aetiology of Upper GI Adenocarcinoma Aetiology of Upper GI Adenocarcinoma
Cancer of mid+ distal stomach Cancer of mid+ distal stomach
Hypochlorhydria Hypochlorhydria
Atrophic gastritis Atrophic gastritis
Low socioeconomic class Low socioeconomic class
Adenocarcinoma of oesophagus Adenocarcinoma of oesophagus
and cardia and cardia
H.Pylori H.Pylori - - ve ve
Middle social class Middle social class
H.Pylori   H.Pylori  +ve +ve
Normal  Normal secretory secretory function function
Healthy mucosa Healthy mucosa
 
Figure 1.4:. Aetiology of upper GIT adenocarcinoma (cardia versus non cardia). Chapter 1    27 
1.3.3  Risk factors of gastric and oesophagus adenocarcinoma 
The pathogenesis of gastric cancer in general, and adenocarcinoma of the oesophagus and 
gastric cardia in particular, are complex with multiple steps and multi-factorial processes. 
However, the disease is the end-result of cellular and molecular changes triggered by 
endogenous and environmental factors 
(32, 33). The mutagen responsible remains unknown, 
but important clues have been established and are discussed below 
(34). 
  Gastro-oesophageal reflux  
Gastro-oesophageal reflux is a strong risk factor in the development of adenocarcinoma of 
the oesophagus 
(19, 35). Chronic exposure to gastric and bile acid leads to progressive 
damage and changes to the squamous mucosa of the oesophagus and causes its 
replacement by metaplastic columnar mucosa. The longstanding damage caused by gastric 
and bile reflux to the oesophageal squamous mucosa transforms it to gastric columnar 
mucosa, then into intestinal mucosa followed by dysplasia and finally adenocarcinoma
 (14, 
36). However, the sequence of events leading to oesophageal adenocarcinoma is not 
mandatory for the development of the disease, although large cohort studies have 
established a strong association between reflux disease and oesophageal adenocarcinoma 
(37).   
The aetiology of adenocarcinoma of gastric cardia remains unknown; however, it may 
have a similar aetiology to oesophageal adenocarcinoma 
(18, 25-27). Many studies have 
shown there are weak associations between the reflux disease and adenocarcinoma of 
cardia 
(35, 37). However, recently several studies have established that cardia cancer might 
arise from the distal segment of the oesophagus mucosa when this segment is exposed to 
acid but the oesophageal sphincter does not allow the acid to reflux into the main body of 
the oesophagus
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This explanation suggests that cardia cancer might resemble the oesophageal 
adenocarcinoma, and therefore may have at least two different aetiological factors.  
  Helicobacter  pylori infection 
Recent studies have indicated that infection with H. pylori might be inversely associated 
with the risk of adenocarcinoma of the oesophagus and gastric cardia 
(39). However, this 
association between the H. pylori infection and adenocarcinoma of the cardia is much 
weaker than that of between H. pylori infection and oesophageal adenocarcinoma 
(40, 41). 
The postulated mechanism for the protective effect might be that infection could reduce the 
occurrence of acidic reflux by introducing atrophic gastritis, which in turn would reduce 
the harmful effects of acidity in the oesophagus 
(42). Moreover, the eradication of H. pylori 
infection in individuals might lead to an increase in the incidence of oesophageal 
adenocarcinoma. However, the causal relation between the two remains unclear 
(19). 
The association between H. pylori infection and gastric cancer may vary by the anatomical 
site; many studies have demonstrated that H. pylori infection is associated with a risk of 
non-cardia cancer 
(31, 40, 43). However, the association with adenocarcinoma of gastric cardia 
is very complex and some studies have pointed out that H. pylori infection is not involved 
in the aetiology of cardia cancer 
(40, 41). In contrast, other studies have confirmed there is an 
inverse association between the H. pylori infection particularly cagA
+  strains, and 
adenocarcinoma of gastric cardia 
(39, 44, 45). Furthermore, recent studies have examined the 
relationship between the intra-gastric location of cancer, H. pylori infection, and atrophic 
gastritis 
(44). These studies have confirmed that there is a strong association between H. 
pylori infection and atrophic gastritis and cancer of non cardia. However, a significant 
negative association between H. pylori infection and cardia cancer has also been detected. 
Individuals who are seropositive for H. pylori are at an increased risk for gastric cardia 
cancer particularly if they had atrophic gastritis 
(44).  Chapter 1    29 
This view is consistent with the fact that cardia cancer is a complex disease and has at least 
two distinct aetiologies 
(46). One type resembles non-cardia cancer being associated with H. 
pylori infection and atrophic gastritis. The other type resembles the oesophageal 
adenocarcinoma and this type is shown to have a negative association with H. pylori 
infection and is more likely to be due to short segment gastro-oesophageal reflux disease 
(14).  
Moreover, there is geographical variation between the H. pylori infection and gastric cardia 
cancer. For example, there is a strong negative association between H. pylori infection and 
cardia cancer in Western countries, while there is a positive association between H. pylori 
infection and cardia cancer in China and other Eastern countries 
(40).  
  Luminal chemistry of the gastric cardia  
Recently many studies have pointed out that the luminal chemistry of the cardia region is 
different from the rest of the stomach. For example, the post-prandial acidity of gastric 
juice is decreased in the body of the stomach due to the buffering effect of food. However, 
the GOJ and gastric cardia are escape the buffering effect of meals and remain highly 
acidic compared to the body of the stomach. Thus the acidity of gastric cardia would 
facilitate the chemical reaction occur at low pH 
(47). The formation of nitrosating species 
and N-nitroso compounds from salivary nitrite, derived from dietary nitrate, in the acidic 
environment of the stomach is maximal at the cardia region 
(48-50). These N-nitroso 
compounds are potential pre-carcinogens for the oesophagus and stomach in animals 
models 
(51). Ascorbic acid, actively secreted in gastric juice, provides protection by 
converting nitrosating species to nitric oxide 
(52-54). The luminal generation of nitric oxide 
(the reaction between nitrosating species and ascorbic acid) is maximal at GOJ and gastric 
cardia 
(50, 55-57). Nitric oxide is known to be mutagenic through its ability to react rapidly 
with oxygen to form N2O3, which can damage DNA directly via deamination of bases or 
indirectly through generation of N-nitroso compounds 
(58-61). Moreover, nitric oxide can Chapter 1    30 
inhibit a number of DNA repair enzymes 
(62) . Furthermore at this anatomical site the 
nitrite:ascorbic acid ratio is higher than any other region of the stomach
 (48). There is also a 
substantial concentration of thiocyanate, which is an important catalyst in this chemistry
 
(48). All of these observations indicate that the GOJ and cardia region of stomach are likely 
to be regions of high nitrosative stress; mechanisms may contribute to a high incidence of 
metaplasia and neoplasia at these anatomical sites.  
1.4  Luminal nitrosative chemistry 
1.4.1  Nitric oxide 
Nitric oxide is an important free radical playing a significant role in various biological 
events. In general, nitric oxide has beneficial regulatory functions in cardiovascular, 
immune and nervous system 
(63-65). Nitric oxide is involved in the regulation of gastric 
mucosa blood flow, mucus secretion and gastric motility, as well as being implicated in 
gastrin and gastric acid secretion
 (66-68). Furthermore, it has an important antimicrobial 
activity against a large variety of pathogenic micro-organisms 
(69-71). However, imbalance 
of this biological molecule secretion is implicated in a number of different diseases such as 
hypertension, arteriosclerosis, diabetes and neurodegenerative disorders 
(63, 65, 72, 73). 
Nitric oxide is produced from the amino acid L- arginine by the enzyme NO synthase and 
there are three isoforms of nitric oxide synthase enzyme
(74). Nitric oxide is generated at 
low concentration (constitutive nitric oxide synthase) by endothelial type (e NOS) neuronal 
type (n NOS) to modulate neuromuscular and vascular function. While the inducible form 
NO synthase (i NOS) produced nitric oxide at high concentration in order to influence the 
immune and inflammatory response 
(74, 75). The nitric oxide  generated by the inducible 
form has been implicated in the aetiology of mutagenesis and neoplasia related to chronic 
inflammation
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Over the last decades, in addition to enzymatic production another alternative pathway 
(non enzymatic) has been described, which generated large concentration of nitric oxide in 
the stomach 
(57, 77). Nitric oxide arises from the reduction of nitrite, derived from entero-
salivary recirculation of dietary nitrate, to nitrosating species and nitric oxide (in presence 
of ascorbic acid) under the acidic condition of the stomach 
(53-55, 57). 
1.4.2  Dietary nitrate and entero-salivary recirculation. 
Over the last two decades, there has been concern about the role of luminal nitrite in the 
aetiology of human gastro-oesophageal junction and gastric cardia malignancies.
(49, 78) This 
arises from the fact that the acidic environment of the stomach converts nitrite in the saliva 
to nitrous acid and nitrosating species 
(28, 49, 78). These nitrosating species can generate 
potentially carcinogenic N-nitroso compounds through their ability to react with secondary 
amines and amides 
(28, 49, 78). The major source of nitrite in gastric juice of the healthy 
stomach is swallowed saliva, which in turn is derived mainly from the entero-salivary 
recirculation of dietary nitrate
(79, 80).The main dietary source of nitrate is green leafy 
vegetables; after ingestion nitrate is rapidly absorbed from the small intestine into the 
blood and it reaches its maximum plasma concentration after sixty minutes from ingestion. 
Most of the nitrate is excreted in the urine, while only about 20-30% of all nitrates (from 
dietary source or produced endogenously) is re-circulated and taken up by the salivary 
glands and secreted into the mouth 
(79, 81-84). The nitrate-reducing bacteria on the dorsum of 
the tongue reduce at least 25% of that nitrate to nitrite (Figure 1.5) 
(83, 85, 86). Approximately 
1500 ml of saliva is swallowed every 24 hours, containing high concentrations of nitrite as 
a consequence of the reduction of dietary nitrate. Under fasting conditions, the nitrite 
concentration of saliva is approximately 50 µM and this increase to 200 µM after ingestion 
of a nitrate-rich meal 
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1.4.3  Acid catalysed nitrosative stress  
When the nitrite-rich saliva reaches the stomach and encounters the acidic gastric juice, 
nitrite is rapidly converted to nitrous acid and nitrosating species such as N2O3, NO
+ (28, 49, 
78). The latter reacts with thiocyanate (SCN), which is derived from the diet (milk and 
vegetables) and also secreted by salivary glands, at a considerable concentration, to form 
the particularly potent nitrosating species NOSCN 
(89-92). In addition, thiocyanate is 
secreted directly into the gastric juice 
(89). Thiocyanate concentration in saliva is much 
higher in smokers than non-smokers as a consequence of the detoxication of cyanide 
compounds in tobacco 
(93). These nitrosating species can react with a variety of organic 
nitrogenous compounds to regenerate potentially carcinogenic N-nitroso compounds 
(49, 78). 
Over the last two decades, N-nitroso compounds have been used as carcinogens in animal 
models of the GOJ and gastric cardia of the stomach 
(94). In addition, these nitrosating 
species can trigger oxidative stress in gastric mucosa by inducing more consumption of 
local antioxidants; this mechanism may be relevant to upper gastrointestinal tract 
malignancies 
(48, 53).  
The main factor protecting against the formation of the N-nitroso compounds, formed by 
the reaction between the nitrosating species and intra-gastric amines and amides, is 
ascorbic acid 
(52, 54, 95-97). Ascorbic acid actively competes with secondary amines and 
amides for nitrosating species, preventing nitrosation 
(54, 98-100). In this reaction, ascorbic 
acid reacts with nitrosating species and the latter is reduced to nitric oxide and the former 
oxidized to dehydro ascorbic acid 
(52-54, 101). Stoichiometrically, one molecule of ascorbic 
acid should convert two molecules of nitrite in acidic conditions to nitric oxide 
(102). 
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Figure 1.5: Dietary nitrate and entero-salivary recirculation, 25% of dietary nitrate is re-circulated, 
taken up by salivary glands and reduced to nitrite by the reducing bacteria on the dorsum of the 
tongue. The nitrite in the swallowed saliva is immediately converted to nitrous acid and nitrosating 
species such as N2O3, NO
+ when encounter acidic gastric juice. Further reaction with ascorbic acid 
takes place to produce nitric oxide and the former is oxidised to dehydroascorbic acid. The gastric 
cardia is where the nitrite in saliva first meets gastric acid, however, in patients with GORD the 
reactant site is the distal oesophagus 
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Previous studies have reported that the active luminal nitrite chemistry takes place where 
the reactants first meet (i.e. when the nitrite in saliva encounters acidic gastric juice) 
(48, 87). 
In the healthy acid-secreting stomach, the gastric cardia is the site where nitrite in saliva 
first meets gastric acid. However, in the patient with gastro-oesophageal reflux disease, the 
reaction site is moved proximally. Thus, the distal oesophagus instead of the cardia region 
has the highest concentration of nitrosating species and nitric oxide where the refluxing 
gastric acid meets the saliva 
(48, 55, 87, 103). In addition, at these anatomical locations there is 
maximum local consumption of antioxidants in gastric juice, particularly ascorbic acid, as 
a result of active luminal chemistry 
(53). 
It is also important to highlight the chemical environment of proximal gastric cardia and 
GOJ which may be relevant to high incidence of mutagenesis and neoplasia. Firstly at 
these locations, the nitrite to ascorbic acid ratio is high. Secondly, there is an adequate 
concentration of thiocyanate, which is an important catalytic agent for the nitrite 
conversion reaction, consequently causing the more rapid consumption of ascorbic acid. 
Thirdly, oxygen tension, swallowed food is the main source of oxygen delivered into the 
stomach; in addition to the epithelial cells, which are contains oxygen as well. In the 
presence of oxygen nitric oxide re-forms nitrosating species and this recycling pathway 
will continue until either the oxygen or ascorbic acid is completely consumed. Finally, 
gastric juice acidity is an important factor for the conversion reaction of nitrite to 
nitrosating species and it increases the rate of the recycling pathway 
(48, 53, 55, 87, 103, 104). 
This suggests that in the healthy acid secreting stomach, the gastric cardia of the stomach is 
most fulfilling these criteria, while in patients with GORD the distal oesophagus is the 
optimal site. Indeed this might contribute to the high incidence of metaplasia and neoplasia 
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Therefore, an investigation of the influence of ascorbic acid, thiocyanate, oxygen tension, 
and different pH values on nitrite chemistry at the human GOJ was important.  
1.5  Inhibition of nitrosative stress by vitamin C  
Vitamin C is one of the most essential vitamins for good human health, as it plays an 
important role in numerous biological systems and also has a protective effect against 
carcinogenesis processes in many cells 
(105). It acts as co-factors for many enzymes, which 
are involved in the synthesis of hormones, neurotransmitters, collagen, and other 
substances 
(106). In addition, several studies have confirmed that it is one of the most 
important antioxidants in the aqueous fluid of most living tissues, as it neutralises the 
reactive oxygen and nitrogen species 
(99, 107, 108). 
Vitamin C has two major forms: ascorbic acid (AA) and dehydroascorbic acid (DHA), and 
both of these forms have vitamin C activity and are inter-convertible by redox chemistry 
(109) . Under fasting conditions vitamin C is present in gastric juice mainly in the reduced 
form, ascorbic acid
(54, 110) and is a potent antioxidant known to prevent gastric 
carcinogenesis through it ability to quench free radicals and inhibit nitrosamine 
formation
(101, 111, 112). 
However, little is known about the regulation of ascorbic acid secretion by gastric mucosa, 
other than that it is concentrated in the gastric mucosa and then actively secreted into 
gastric juice reaching a concentration of 20-300µM 
(52, 54, 113, 114). Many factors affect the 
ascorbic acid concentration in gastric juice, for example, elevated pH of the gastric juice; 
chronic gastritis and infection with H. pylori significantly reduce the ascorbic acid 
concentration in gastric juice 
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The main protective effect of ascorbic acid is not only that it neutralises the harmful DNA 
damaging effect caused by free radicals generated by H. pylori infection or smoking 
(117, 
118). Ascorbic acid reduces N-nitroso compounds formation by actively competing with 
secondary amines and amides for reaction with nitrosating species 
(54, 98-100, 112). Ascorbic 
acid has a protective effect against gastric carcinogenesis through its ability to quench 
nitrosating species as well as inhibiting N-nitroso compounds formation in gastric juice. 
However, it has been recognised that the luminal nitric oxide can react with oxygen and re-
form nitrosating species, which can react with any remaining ascorbic acid 
(61, 104, 119, 120). 
The rate of the reaction between nitric oxide and oxygen is increased by increasing the 
nitric oxide concentration, as it is related to the concentration of oxygen and the square of 
the nitric oxide concentration 
(61). The recycling of nitric oxide in the presence of oxygen to 
re-form the nitrosating species continues until the ascorbic acid is depleted and this induces 
more nitrosative stress 
(48, 50, 104). Moreover, the nitrosating species such as N2O3  are 
potentially carcinogenic compound directly through their ability to deaminate DNA bases 
or indirectly by forming of N- nitroso compounds 
(58-60). Furthermore, nitric oxide in high 
concentration is shown to be mutagenic via the inhibition of a number of DNA repair 
enzymes 
(62). 
 
However, recent studies have demonstrated that ascorbic acid may promote the nitrosation 
reaction within the epithelial lipid compartment despite inhibiting nitrosation within the 
luminal compartment 
(53, 121). This due to that the nitric oxide generated by the reaction 
between salivary nitrite and ascorbic acid diffusing into adjacent epithelial cells and lipid 
compartments and reacting there with oxygen to generate N2O3 
(56, 57, 61). Indeed, the rate of 
reaction between the nitric oxide and oxygen is more rapid within the lipid than the 
aqueous compartment because both are more soluble in lipid than aqueous solutions 
(60, 122). 
Thus, the  presence of the lipid transforms the effect of ascorbic acid from a protecting 
against to promoting nitrosation 
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catalysed nitrosative chemistry (Figure 1.6). The lipid converts the effect of ascorbic acid 
from a inhibiting to promoting N-nitroso compounds formation. The ascorbic acid 
completely inhibits N-nitrosamines formation in the aqueous phase but not in the presence 
of the lipid 
(121). 
Thus, other dietary antioxidants such as dietary phenolics have attracted considerable 
attention in recent years, as a consequence of ascorbic acid poor lipo-solubility and it is 
limitation in the adjacent lipid compartment.  
 
Figure 1.6: Proposed mechanism of N-nitrosamine formation in a dual-phase system on the presence of 
AA in the aqueous phase 
(121).  
 
1.6  Dietary antioxidants 
1.6.1  Phenolics in the diet 
Dietary antioxidants have received considerable attention and interest in recent years. This 
arises from evidence that they may have beneficial effects against reactive oxygen species 
(ROS) and reactive nitrogen species (RNS). These ROS and RNS have been implicated in Chapter 1    38 
the aetiology of many diseases such as cancer of the oesophagus and gastric cardia 
(123-125). 
One the most important natural dietary antioxidants are dietary phenolics 
(126-129). These 
water-soluble phenolic antioxidants are naturally present in the human diet, in a variety of 
fruits and vegetables as well as most beverages 
(130, 131). It has been suggested that dietary 
phenolics play a beneficial role against nitrosation and nitrating species, however, their 
exact mechanism of action is still unclear 
(127, 132, 133). 
Phenolic compounds are one of the major groups of polyphenol compounds, which consist 
of flavonoids, stilbenes, and lignans 
(130). These polyphenol compounds are classified into 
different groups according to their phenol rings and the elements that bind these rings 
(130, 
131). In this study we examined a range of phenolics: caffeic acid (CA), ferulic acid (FA), 
chlorogenic acid (CGA), and gallic acid (GA). Gallic acid, belonging to the 
hydroxybenzoates, is mainly found in tea (tea leaves contain up to 4.5g/kg) and fruits while 
caffeic acid, ferulic acid, and chlorogenic acid belonging to the hydroxycinnamates, and 
are found in coffee and a variety of fruits such as apples, pears, peaches, plums 
(130, 131). 
Vegetables (stems and leaves) are also an important source of dietary phenolics 
(130, 131). 
Dietary phenolics are believed to have an important beneficial effect on human health. 
Many studies have evaluated the antioxidant activity of phenolic compounds in relation to 
atherosclerosis 
(134-136) . However less attention has been paid to the antioxidant activities 
of phenolic compounds in relation to gastric cancer. Therefore, an investigation of the 
antioxidant activity of dietary phenolics is important.  
1.6.2  Antioxidant capacities 
The stomach, particularly the cardia is subjected to many oxidative stresses (ROS and 
RNS) 
(48, 50, 53). The production of nitrosating species, which are derived from the 
acidification of nitrite, can cause injury to gastric mucosa and play a significant role in the Chapter 1    39 
aetiology of gastric adenocarcinoma 
(28, 49, 78). Several studies have shown that an increased 
intake of dietary antioxidants may be associated with a lower risk of gastric cancer 
(123-125, 
137). The exact mechanism by which these dietary antioxidants may reduce the risk of 
gastric cancer has not been completely elucidated, although some studies suggested these 
antioxidants may provide protection against cancer by scavenging the nitrosating species 
and inhibiting the formation of N-nitroso compounds 
(127, 132, 133). Several studies have 
reported that caffeic acid and related compounds provides protection against the N-
nitrosamine compounds (reaction of nitrite and secondary amines in gastric juice) by the 
inhibition of the N-nitrosation reactions 
(138-140). Furthermore, chlorogenic acid and related 
polyphenols competitively inhibit the nitrosation reaction of DNA by the nitrosating agent 
produced by nitrite under acidic conditions 
(141) and this may contribute to the protective 
effects
 of dietary phenolics against gastric cancer.   
Moreover, recently many studies have demonstrated that the consumption of green tea 
inhibits nitrosation by competing with secondary amines for the nitrosating species 
(142, 143).  
1.7  Aim 
The aim of this in vitro study was to model the chemical reactions occurring at the human 
gastro-oesophageal junction (GOJ) after ingestion of nitrite; a mechanism which may be 
relevant to upper GI malignancies. The study aimed to elucidate the role of ascorbic acid 
(AA), sodium thiocyanate (NaSCN), different pH values (1.5, 2.5 and 3.0) and oxygen 
(O2) on the nitrite chemistry in the simulated gastric juice.  
This study also investigated the influence of a range of water- soluble dietary phenolics on 
the nitrite chemistry at simulated GOJ environment to compare their effect with that of 
ascorbic acid.   
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2.1  Chemicals and reagents 
All chemicals (solvents and reagents) used in the studies were obtained from Sigma 
Aldrich (Poole, UK), except the ethylenediaminetetraacetic acid (EDTA) which was 
obtained from BDH Ltd., (Liverpool, UK).  
2.2  The bench-top model 
All studies were performed in a purpose-designed closed bench-top model, representing 
the human gastro-oesophageal junction, to study the chemical reaction occurring when 
nitrite encounters the simulated gastric juice. These studies focused on the measurement of 
nitric oxide formation and oxygen consumption by electrochemical detection. 
The model consisted of a glass cylinder (75 mm tall and 25 mm internal diameter) 
equipped with a tight-fitting cap with two ports enabling insertion of the electrochemical 
nitric oxide and oxygen probes, as well as a third sampling port (Figure 2.1). The nitric 
oxide and dissolved oxygen meters were interfaced to a computer, converting the electrical 
signal (volts) to nitric oxide concentration in µM and oxygen level in %, respectively. 
The capped glass cylinder was filled with 36ml of simulated gastric juice. The simulated 
gastric juice (HCl, 0.1M, pH 1.5) contained 1mM EDTA, 1mM sodium thiocyanate 
(NaSCN), and ascorbic acid or phenolic acid. Ascorbic acid (AA) was tested in final 
concentrations of 100µM, 500µM or 2000µM in parallel with negative controls. Dietary 
phenolics including ferulic acid, caffeic acid, gallic acid, and chlorogenic acid were tested 
in final concentrations of 250µM and 2000µM.  
The system was immersed in degassed water and the experiments carried out in a 37°C 
water bath (Figure 2.1). The total incubation time was 70 minutes and the assay was 
initiated by adding NaNO2 after ten minutes from incubation. Chapter 2    42 
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Figure 2.1 The bench-top model, (A) photograph and (B) diagram, representing the human GOJ, to 
study the chemical reactions occurring when nitrite encounters the simulated gastric juice Chapter 2    43 
Elimination of oxygen from the system 
One of the most important shortcomings of the early experimental set-up under anaerobic 
condition was the entry of oxygen into the system. To overcome this problem, a tight 
fitting cap was especially designed. The system was then immersed under deoxygenated 
water to reduce any entry of oxygen into the system. Indeed, it was found in subsequent 
experiments that this set-up resulted in the maximum reduction of oxygen entering the 
system. Furthermore, to achieve anaerobic conditions, the head space of the capped 
cylinder was filled with argon gas.  
2.3  Assay set-up 
To study the influence of AA, NaSCN, O2 and different pH values (1.5, 2.5 and 3.0) on the 
nitrite chemistry was carried out in a bench-top model; described under section 2.2.  
To investigate the influence of ascorbic acid in nitrite chemistry, the simulated gastric juice 
(HCl, 0.1M, pH 1.5) contained 1mM EDTA, 1mM NaSCN, in the absence or presence of 
ascorbic acid (100µM, 500µM or 2000µM).    
Under aerobic conditions, the contents of the cylinder were aerated for two minutes before 
the incubation, whereas for anaerobic conditions the dissolved oxygen was removed from 
the solutions by purging helium through it for 5- 10 minutes, followed by a flow of argon 
to fill the headspace of the capped cylinder.  
The contents of the cylinder were constantly mixed with a magnetic stirrer and the system 
was immersed under water, which was also purged with helium and placed in water bath at 
37°C (Figure 2.1).  
The assay was initiated by the addition of sodium nitrite (100 µM) at t=10 minutes and the 
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Furthermore, to investigate the influence of other parameters on the nitrite chemistry, each 
of the experiment was performed with and without NaSCN (1mM), at different pH values 
(1.5, 2.5 or 3.0) under both aerobic and anaerobic conditions.  
Samples were taken from the cylinder to measure the AA and DHA at the start and end 
(50µl or 500µl) respectively, of the incubation period. All experiments were carried out in 
duplicate. 
To assess the influence of a range of dietary phenolics on nitrite chemistry in comparison 
with ascorbic acid, the studies were carried out in the bench-top model described under 
section 2.2. The simulated gastric juice (HCl, 0.1M, pH 1.5) contained 1mM EDTA, 1mM 
NaSCN, in the presence of either ascorbic acid or dietary phenolics. The dietary phenolics, 
including ferulic acid, caffeic acid, gallic acid and chlorogenic acid were tested in final 
concentrations of 250µM and 2000µM. The studies were performed under both aerobic 
and anaerobic conditions. All experiments were carried out in duplicate. 
2.3.1  Nitric oxide measurement 
Nitric oxide levels were monitored with an isolated dissolved nitric oxide electrode and 
meter (ISO – NO Mark II; World Precision Instruments, Sarasota, Florida, U.S.A). The 
nitric oxide probe was calibrated by adding successive bolus of 50µl NaNO2 (0.7µM) to 
sulphuric acid (0.1 M) containing potassium iodide (0.1M) in a starting volume of 36 ml. 
Before adding the bolus of NaNO2 to the solution, dissolved oxygen was removed by 
purging the system with helium for five minutes. Under these conditions, nitric oxide 
concentration in the solution was equal to nitrite concentration, i.e. one mole of nitrite 
produces one mole of nitric oxide. The NO meter was interfaced to a computer, converting 
the electrical signal (volt) to nitric oxide concentration in µM; the electrode response was 
linear to the range of concentrations tested (Figure 2.2A and B).  Chapter 2    45 
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Figure 2.2 Calibration of nitric oxide probe, (A) by adding successive bolus dose of 50µl NaNO2 to 
sulphuric acid (0.1M) containing potassium iodide (0.1M), and (B) obtaining a linear response between 
electrical signal of NO (volts) and NO concentration (µM).).  
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2.3.2  Oxygen Measurement 
The dissolved oxygen in the solution was monitored using an isolated dissolved oxygen 
meter and electrode (Mark II, World Precision Instrument Inc., Sarasota, U.S.A). The 
oxygen probe was calibrated at 37ºC by repeatedly transferring the probe between two 
beakers filled with aerated HCl (20.4% oxygen) and degassed HCl (bubbling helium 
through) under constant stirring. The NaSCN (1mM), AA (2000µM) and NaNO2 (100µM) 
were added to degassed HCl in order for the meter to display zero% of oxygen (Figure 
2.3A and B).  
(A) 
 
(B) 
 
Figure 2.3 Calibration of oxygen probe, (A) the arrow is indicates the time of the addition of NaSCN, 
AA, and NaNO2 and (B) obtaining a linear response between electrical signals of O2 (volts) andO2 
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One of the major difficulties of these experiments was the accurate calibration of the 
oxygen probe. The difficulties were mainly due to the extremely sensitive nature of the 
probe to achieve a right calibration. Any inaccuracy in the calibration process can result in 
over- or under-estimation of the value of the dissolved oxygen in the solution. This, in turn, 
would undermine the measurement processes. Therefore, great care was taken during the 
calibration of the oxygen probe. Indeed, it was common practice to calibrate the oxygen 
probe daily before starting the experiment. It was found that with this practice the 
experiments were highly reproducible. 
2.4  Sampling procedure 
Before starting the reaction, two 50µl samples were taken from the cylinder to be used to 
measure the baseline values of ascorbic acid (AA) and dehydroascorbic acid (DHA). After 
sixty minutes from the addition of nitrite, a further two samples (500µl) were taken to 
assess final AA/ DHA levels.  
The samples for AA measurement (50µl or 500µl) were added to Eppendorf tubes 
containing an equal volume of 2% metaphosphoric acid and 0.5% sulfamic acid. The 
samples for DHA measurement (50µl or 500µl) were added to Eppendorf tubes containing 
an equal volume of 6 mg/ml dithiothreitol (DTT) and 2% metaphosphoric acid.  
The purpose of the DTT was to generate AA from any DHA in the sample, thus allowing 
quantification of the total vitamin C (TVC) levels, allowing the amount of DHA present in 
the sample to be estimated by subtracting AA from TVC. To remove any remaining nitrite, 
sulfamic acid was added to the sample. All samples were kept at - 20°C until analysis by 
high performance liquid chromatograph (HPLC), based upon the method of Sanderson and 
Schorah 
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2.4.1  Ascorbic acid analysis 
Before the analysis, samples were thawed and centrifuged at 1000g ALC (Multi-Speed 
Refrigerated Centrifuge) (CPK 131R) from Thermo Life Sciences. Remove 0.3ml of the 
samples supernatant were further centrifuged in a minifuge at 9000g (Mini-spine, 
Eppendorf). AA and TVC levels were measured by HPLC. The instrumentation was 
comprised of a Shimadzu L-ECD-6A Electrochemical Detector, Shimadzu LC-10AT VP 
pump, and Shimadzu model SIL-10AD VP with 50µl loop injector. AA was measured 
using reverse- phase on a Phenomenex 5µm C 18 Luna analytical column 150 x 4.6 mm 
and protected by an Anachem guard column 20 x 3 mm; Packing Material, Lichroprep RP-
18 (25-40µm). The acetate buffer solution consisted of 0.1M sodium acetate and 0.1M 
octylamine adjusted to pH 4.3 using 50% acetic acid. The mobile phase pumped through 
HPLC consisted of 85% acetate buffer and 15% acetonitrile. The flow rate was 0.8ml/min, 
generating a column pressure of approximately 1000psi. The retention time of AA was 2.4 
minutes. The aqueous stock standard solution was prepared by adding 5 mg AA to 5.0ml 
of DDT (3.5mg/ml) in MPA/SA 50/50 volumes. In working standards of 5, 10, 20, 30, and 
40µg/ml of AA were prepared by taking 50, 100, 200, 300 and 400 ml of 1 mg/ml AA 
stock standard solution (1mg/ml), making the volume up to 10 ml in MPA/SA 50/50 
volumes. The auto-sampler was programmed to inject 25µl aliquots of standards and 
samples. To remove the oxidizing sites on the column 25µl of the DDT solution was 
injected prior to the standards and samples. The number of injections through the HLPC 
was restricted to 55 due to the decomposition of AA, these include the standards before 
and after  two sets of 20 samples 
(145, 146). 
2.5  Data analysis 
All the data is presented as mean values of two experiments.  The nitric oxide and oxygen 
values were highly reproducible and thus only two experiments performed per study and Chapter 2    49 
presented as mean value.   The Pearson correlation coefficient (CC) was calculated for 
typical experiments in which there were changes in nitric oxide values with time 
(experiment 3.1.2) between the two duplicates and this gave values of CC=0.75, 0.97 and 
0.91 for 100µM, 500 µM and 2000 µM, respectively.  Similarly, for experiment 3.1.3 
where oxygen varied with time and again the changes in the mean values of the two 
duplicates of the each experiment were correlated tightly, the Pearson correlation 
coefficient were 0.79, 0.91 and 0.63 for 100µM, 500µM and 2000 µM, respectively. The 
statistical analysis of data of ascorbic acid results was performed either by ANOVA or by 
Student t- test. Statistically significance of the differences was depicted with P value of 
less than 0.01 and 0.05. 
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OVERVIEW 
In this chapter experimental results are presented using the simulated gastric juice system 
described in Chapter 2.2, to study the role of various factors affecting nitrite chemistry at 
the simulated GOJ environment.  
Also presented are the effects of a range of dietary phenolics (water-soluble antioxidant) 
on the nitrite chemistry and a comparison of their effect with ascorbic acid. 
The study focused on the measurement of NO and O2 levels by electrochemical detection. 
The result of these sections is followed by brief discussion. 
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3.1  Nitrite chemistry in the simulated gastric juice: effect of ascorbic 
acid 
3.1.1  Nitric oxide and dissolved oxygen levels following nitrite addition in the 
absence of ascorbic acid 
The addition of nitrite (100µM) to the simulated gastric juice (with NaSCN, pH 1.5, under 
aerobic condition) in the absence of ascorbic acid only led to a limited amount of nitric 
oxide being formed (0.34µM) (Figure 3.1). Meanwhile, dissolved oxygen levels decreased 
slightly after nitrite addition (from 20.7% to18.7%) before returning to baseline levels at t= 
70 minutes (Figure 3.1).  
Figure 3.1: Nitric oxide levels (µM) (squares) and dissolved oxygen levels (%) (triangles) in the 
simulated gastric juice (NaSCN, pH 1.5) following nitrite addition (100µM) at t=10 min, in absence of 
ascorbic acid under aerobic condition. Values are presented as mean of two experiments. 
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3.1.2  Nitric oxide levels following nitrite addition in presence of different 
concentrations of ascorbic acid 
When ascorbic acid was present in the system described under 3.1.1, it increased the 
production of nitric oxide and produced a more marked fall in oxygen concentration 
(Figure 3.2 and 3.3). With ascorbic acid 100M, the nitric oxide concentration reached a 
peak value of 17.45M one minute after the addition of nitrite. The nitric oxide 
concentration then slowly decreased to 2.2M by the end of the incubation time period. 
With ascorbic acid 500M, the nitric oxide concentration peaked at 68M approximately 
five minutes after the addition of nitrite and then fell to 3M after thirty minutes. With 
ascorbic acid 2000M, the nitric oxide rose in a similar manner to that observed following 
ascorbic acid 500M, reaching a value of 63.1M at ten minutes. However, unlike the two 
lower concentrations of ascorbic acid, the nitric oxide concentration following ascorbic 
acid 2000M remained elevated throughout the duration of the experiment (Figure 3.2).   
 
Figure 3.2: Nitric oxide levels (µM) in the simulated gastric juice (NaSCN, pH 1.5), following nitrite 
addition (100µM) at t=10 min, in presence of ascorbic acid 100µM (squares), 500µM (triangles) or 
2000µM (circles) under aerobic condition. Values are presented as mean of two experiments. 
The CC between the two duplicates was 0.75, 0.97 and 0.91 for 100µM, 500µM and 2000µM, 
respectively. 
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3.1.3  Dissolved oxygen levels following nitrite addition in presence of different 
concentrations of ascorbic acid 
In the presence of ascorbic acid 100M, the rise in nitric oxide concentration was mirrored 
by a fall in oxygen concentration from a baseline value of 20% to 16% one minute after the 
addition of nitrite. Thereafter, the oxygen concentration remained steady or slightly 
increased back towards baseline level. With ascorbic acid 500M, the more marked rise in 
nitric oxide was mirrored by a more marked fall in dissolved oxygen concentration with 
the nadir of oxygen concentration occurring at five minutes after the addition of nitrite 
being only 1% and then slowly increasing and returning to 15% by the end of the 
experiment. With ascorbic acid 2000M, the oxygen concentration decreased to become 
undetectable within the first three minutes and remained undetectable throughout the 
duration of the experiment (Figure 3.3). 
 
Figure 3.3: Dissolved oxygen levels (%) in the simulated gastric juice (NaSCN, pH1.5), following nitrite 
addition (100µM) at t=10 min, in presence of ascorbic acid 100µM (squares), 500µM (triangles) or 
2000µM (circles). Values are presented as mean of two experiments. 
The CC between the two duplicates was 0.79, 0.91 and 0.63 for 100µM, 500µM and 2000µM, 
respectively. 
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3.1.4  Ascorbic acid measurements 
In the experiment with 100M ascorbic acid, the ascorbic acid was entirely consumed by 
the end of the experiment. In the experiment with 500M ascorbic acid, 91.5% of the 
ascorbic acid was consumed. With 2000M ascorbic acid significant amounts of ascorbic 
acid remained at the end of the experiment with only 32% being consumed (Table 3.1).   
Table 3.1: Ascorbic acid consumed (%) in the simulated gastric juice (NaSCN, pH 1.5), following 
nitrite addition (100µM) in the presence of ascorbic acid 100µM, 500µM or 2000µM over 60 minutes 
incubation, under aerobic conditions. Values are presented as mean of two experiments and their 
statistical difference.  
 
[AA] µM (at t= 0)  AA consumed (%) (at t= 70 min)  P value 
100 99.18    P < 0.05 
500  91.47   P < 0.05 
2000  32.05   P < 0.01 Chapter 3    56 
 
3.1.5  Discussion  
The addition of nitrite 100M to the HCl pH1.5 containing sodium thiocyanate 1mM 
produced only a very small increase in the nitric oxide concentration reaching a peak of 
0.34M. The pKa of nitrite is 3.5 and at the experimental pH of 1.5, the added nitrite is 
converted to nitrous acid, nitrosating species including N2O3, NO
+ and NOSCN, and the 
small concentration of nitric oxide 
(28, 49, 78). When the experiment was repeated in the 
presence of 100M ascorbic acid, the rise in nitric oxide was much more marked reaching 
a peak of 17.45M. This can be explained by the ascorbic acid reacting with the nitrosating 
species with the latter being reduced to nitric oxide and the former being oxidised to 
dehydroascorbic acid 
(52-54, 101).  
 
 
Scheme 3.1:. Nitrite chemistry in acidic aerobic solutions 
(147).  
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In the presence of ascorbic acid 100M, the addition of nitrite also resulted in a fall in the 
dissolved oxygen concentration from 20% to 16% and this fall mirrored the rise in nitric 
oxide. This fall in oxygen can be explained by the nitric oxide formed by the reaction 
between the ascorbic acid and the nitrosating species reacting with the dissolved oxygen to 
form NO2, N2O3, nitrous acid and nitrosating species scheme 3.2 
(61, 104, 119, 120).  
 
Scheme 3.2: Chemical reaction occurring when nitrite encounter the simulated gastric juice containing 
thiocyanate and ascorbic acid under aerobic condition. 
 
The rate of the reaction between nitric oxide and oxygen is directly related to the 
concentration of oxygen and to the square of the nitric oxide concentration 
(61, 119). The 
reaction between the nitric oxide and dissolved oxygen to re-form nitrosating species 
results in recycling of the nitrosating species and thus consumption of the ascorbic acid. Chapter 3    58 
This can explain why only 17.45M nitric oxide was formed when equimolar amounts of 
ascorbic acid and nitrite were present. As the nitric oxide was being produced, it was also 
being consumed by reacting with the oxygen. This recycling also meant that the ascorbic 
acid would be fully consumed; preventing any further formation of nitric oxide and thus 
the nitric oxide concentration fell. In the experiments with ascorbic acid 100M, there was 
no ascorbic acid detectible at the end of the experiment.   
The experiment with the ascorbic acid 500M showed a much more marked rise in nitric 
oxide, a more marked fall in oxygen, and again the great majority of ascorbic acid was 
consumed by the end of the experiment. The changes noted with ascorbic acid 500M can 
again be explained by the mechanism discussed above.   
When the experiment was performed with ascorbic acid 2000M present, clear differences 
were seen from those observed with the lower doses. The nitric oxide concentration 
reached a peak of 63M and remained at this level throughout the study period. In 
addition, the oxygen concentration fell to undetectable levels and remained undetectable 
throughout the experiment. Furthermore, the experiment differed from the earlier 
experiments in that all the added ascorbic acid was not consumed during the experiment. 
The higher concentration of ascorbic acid in this experiment would mean that recycling of 
nitrosating species could continue until the oxygen was completely depleted. In contrast, in 
the earlier experiments the rate controlling factor in the recycling process was the ascorbic 
acid which became completely depleted rather than the oxygen. The complete depletion of 
the oxygen and the persistence of ascorbic acid can explain why the nitric oxide 
concentration remained elevated throughout the experiment without showing any evidence 
of a fall. The main reason for the nitric oxide falling in the earlier experiments was that it 
was reacting with oxygen to re-form nitrosating species and nitrous acid 
(61, 104, 119, 120). In 
the absence of oxygen, this reaction cannot take place. In addition, if any small amounts of Chapter 3    59 
oxygen were to enter the system and react with nitric oxide to re-form nitrosating species 
then the remaining ascorbic acid would rapidly react with these nitrosating species to 
reproduce nitric oxide. 
Though we added nitrite 100M we did not produce nitric oxide100M. There are several 
explanations for this. The first is that some of the nitric oxide may have been lost from the 
system. The second is that during the recycling process some of the products end up as 
nitrate and in this way can no longer be recycled 
(147).  
 
 
 
 
 
 
 Chapter 3    60 
3.2  Nitrite chemistry in the simulated gastric juice: effect of 
thiocyanate 
3.2.1  Nitric oxide and dissolved oxygen levels following nitrite addition in the 
absence of ascorbic acid 
In the absence of ascorbic acid, the change in nitric oxide and oxygen on adding nitrite to 
hydrochloric acid pH1.5 was identical in the presence or absence of sodium thiocyanate 
1mM (Figures 3.4A and B). 
(A) 
 
(B) 
 
Figure 3.4: Effect of thiocyanate, presence (A) and absence (B) on nitric oxide levels (µM) (squares) 
and dissolved oxygen (%) (triangles) in the simulated gastric juice, following nitrite addition (100µM) 
at t=10 min, in absence of ascorbic acid. Values are presented as mean of two experiments. 
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3.2.2  Nitric oxide levels following nitrite addition in the presence of different 
concentrations of ascorbic acid 
When nitrite 100M was added to the HCl pH1.5 containing ascorbic acid 100M in the 
presence of sodium thiocyanate it produced a higher peak nitric oxide concentration of 
17.45M compared with 8.6M in the absence of thiocyanate. In the presence of 
thiocyanate the peak nitric oxide concentration occurred one minute after the addition of 
nitrite and then slowly fell. The rise in nitric oxide in the absence of thiocyanate appeared 
to be slower and not occurring until two minutes after the addition of nitrite (Figure 3.5A).  
With ascorbic acid 500M there was a marked difference in the peak nitric oxide 
concentration reached. In the presence of thiocyanate a peak nitric oxide concentration of 
68M was reached five minutes after adding nitrite. In contrast, the peak nitric oxide 
concentration in the absence of thiocyanate was 20.7M and occurred ten minutes after the 
addition of nitrite. The profile of the rise in nitric oxide was also different in the presence 
and absence of thiocyanate. In the presence of thiocyanate there was a clear rise and then 
clear fall in the nitric oxide concentration. In contrast, in the absence of thiocyanate the 
nitric oxide spheres to plateau at a level of approximately 20M and remained at that level 
between two and ten minutes after adding the nitrite and then it slowly fell (Figure 3.5B). 
With ascorbic acid 2000µM there was a marked rise in nitric oxide both in the presence 
and absence of thiocyanate and in both cases the nitric oxide remained elevated throughout 
the duration of the experiment. However, there did appear to be some differences in the 
profile of the nitric oxide response in the presence versus absence of thiocyanate.  
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(A)
 
(B)
 
(C)
 
Figure 3.5: Nitric oxide levels (µM) in the simulated gastric juice at pH 1.5, on absence of thiocyanate 
(triangles) and presence (squares), following nitrite addition (100µM) at t=10min, in the presence of 
ascorbic acid 100µM (A), 500µM (B) or 2000µM (C) under aerobic condition. Values are presented as 
mean of two experiments. Chapter 3    63 
In the presence of thiocyanate, the initial rise in nitric oxide was more rapid than in the 
absence of thiocyanate and in the presence of thiocyanate the level of the plateau of nitric 
oxide was approximately 15M lower than that obtained in the absence of the thiocyanate 
(Figure 3.5C). 
3.2.3  Dissolved oxygen levels following nitrite addition in presence of different 
concentrations of ascorbic acid 
With the ascorbic acid 100M, the change in oxygen concentration reflected the changes 
in nitric oxide with a more rapid fall in oxygen in the presence of thiocyanate (Figure 
3.6A).   
With the ascorbic acid 500M, the changes in oxygen also reflected the changes in nitric 
oxide. In the presence of thiocyanate the oxygen level fell more rapidly and was almost 
undetectable for five minutes and then slowly increased again. In contrast, in the absence 
of thiocyanate the fall in oxygen was slower, reaching a nadir of 5% at twenty minutes and 
then showing a slow rise (Figure 3.6B).   
With the ascorbic acid 2000M, the oxygen was completely depleted in the presence of 
thiocyanate within the first three minutes and remained undetectable throughout the 
experiment. In contrast the fall in oxygen was less rapid in the absence of thiocyanate, 
reaching a nadir of 1.5% at six minutes and then slowly rising (Figure 3.6C). Chapter 3    64 
(A) 
(B) 
(C)
 
Figure 3.6: Dissolved oxygen levels (%) in the simulated gastric juice on absence of thiocyanate 
(triangles) and presence (squares), following nitrite addition (100µM) at t=10 min, in the presence of 
ascorbic acid 100µM (A), 500µM (B) and 2000µM (C). Values are presented as mean of two 
experiments. Chapter 3    65 
 
3.2.4  Ascorbic acid measurements 
In the ascorbic acid 100M, all of the ascorbic acid was consumed in the presence of 
thiocyanate whereas only approximately 50% was consumed in the absence of thiocyanate. 
In addition with ascorbic acid 500M, 91% was consumed in the presence of thiocyanate 
compared with only 80% in the absence of thiocyanate. With the ascorbic acid 2000M 
substantial amounts remained present in both the presence and absence of thiocyanate 
(Table 3.2). 
Table 3.2 Thiocyanate effect on ascorbic acid consumption (%) in the simulated gastric juice pH 1.5 
under aerobic condition, following nitrite addition (100µM) in presence of ascorbic acid 100µM, 
500µM or 2000µM over 60 minutes incubation. Values are presented as mean of two experiments.  
 
[AA]µM 
at t=0  
AA consumed (%) with  
NaSCN at t= 70 min 
AA consumed (%) without  
NaSCN at t= 70 min  P Value 
100  99.18   44.43   P < 0.05 
500  91.47   80.72   P < 0.05 
2000  32.05   29.24  
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3.2.5  Discussion 
In the presence of thiocyanate, the rise in nitric oxide concentration was more rapid and at 
the two lower concentrations of ascorbic acid, produced a higher peak concentration.  In 
the presence of thiocyanate, at acidic pH, the NO
+ reacts with thiocyanate to form the 
nitrosating species NOSCN 
(49, 78, 90-92). This is the dominant species which is thought to 
react with ascorbic acid to form nitric oxide 
(49, 78, 90-92). In contrast, in the absence of 
thiocyanate the nitrosating species are N2O3 and NO
+. The more rapid rise in nitric oxide 
concentration can be explained by the raised affinity of NOSCN following ascorbic acid 
compared to these other nitrosating species at the pH of this experiment. 
In the experiment with ascorbic acid 500M, the presence of thiocyanate produced a clear 
peak nitric oxide concentration and then clear fall, whereas in the absence of thiocyanate 
there was a lower peak concentration but more of a plateau of nitric oxide with a less rapid 
fall. The more rapid fall in nitric oxide in the presence of thiocyanate may be explained by 
the more rapid consumption of ascorbic acid and the fall in nitric oxide concentration 
occurring when the ascorbic acid has been depleted
(104). The consumption of ascorbic acid 
occurs due to the recycling of nitric oxide and its reactive oxygen to reform nitrosating 
species. In the thiocyanate the fall in oxygen was more rapid. This can be explained by the 
higher concentration of nitric oxide produced in the presence of thiocyanate and the 
reaction between nitric oxide and oxygen being related to the square of nitric oxide 
concentration 
(61, 119, 120). The changes in the ascorbic acid concentration would also be 
consistent with the ascorbic acid being more rapidly consumed in the presence of 
thiocyanate as the concentrations of ascorbic acid at the end of the experiment were lower 
in the presence versus absence of thiocyanate. The slower consumption of ascorbic acid in 
the absence of thiocyanate would mean that when nitric oxide reacted with oxygen to 
reform nitrosating species, the latter could still react with ascorbic acid and reform nitric Chapter 3    67 
oxide. One would therefore have a steady state with the consumption of nitric oxide by its 
reaction with oxygen equal to the rate of its regeneration by the reaction of nitrosating 
species with ascorbic acid and therefore producing the plateau level of nitric oxide.  
In the presence of thiocyanate the oxygen concentration was higher at the end of the 
experiment than in the absence of thiocyanate. The rise in oxygen in the presence of 
thiocyanate can be explained by oxygen diffusing into the system. Though this would also 
happen in the absence of thiocyanate, the persisting nitric oxide in the absence of 
thiocyanate would be able to react with the oxygen converting it into nitrous acid.   
In the experiment with ascorbic acid 2000M, the rise in nitric oxide was more rapid in the 
presence of thiocyanate but the plateau level achieved was slightly lower. The more rapid 
rise in nitric oxide can again be explained by the higher affinity of NOSCN for ascorbic 
acid than that of other nitrosating species. The lower level of the plateau in the presence of 
thiocyanate is likely to be explained by greater recycling of nitric oxide in the presence of 
thiocyanate leading to a greater proportion ending up as nitrate 
(104). The greater rate of 
production of nitric oxide in the presence of thiocyanate will lead to a greater rate of 
recycling and thus a higher proportion of the nitric oxide ending up as nitrate
(104, 147). 
Further evidence of this greater rate of recycling was seen in the fact that the oxygen 
concentration in the presence of thiocyanate fell more rapidly in the presence of 
thiocyanate than in its absence 
(120). 
In the absence of thiocyanate, a small amount of oxygen was still detectible throughout the 
experiment with ascorbic acid 2000M present. In contrast, no oxygen was detectible after 
three minutes in the presence of thiocyanate. The reason for this is unclear. In both 
experiments nitric oxide was maintained at a high level throughout the experiment and 
indeed was slightly higher towards the end of the experiment in the absence of thiocyanate. 
Reasons for this are unclear. Chapter 3    68 
3.3  Nitrite chemistry in the simulated gastric juice: effect of different 
pH values (1.5, 2.5 and 3.0) 
3.3.1  Nitric oxide and dissolved oxygen levels following nitrite addition in the 
presence of different concentrations of ascorbic acid 
With ascorbic acid 100M present, the rise in nitric oxide concentration on adding nitrite 
100M to HCl containing thiocyanate was related to the pH of the HCl. The rise in nitric 
oxide was greatest at the lowest pH of 1.5 and least at pH 3. In addition, the rate of rise in 
nitric oxide was more rapid at pH1.5 and much slower at pH 3 (Figure 3.7A). These 
changes in nitric oxide were reflected in similar changes in degree of fall in the oxygen 
concentration (Figure 3.8A).   
With ascorbic acid 500M the rise in nitric oxide was more marked than with the ascorbic 
acid 100M and again the degree of rise was influenced by the pH. The increase in nitric 
oxide was greatest at pH 1.5 reaching a peak of 68M at five minutes and then falling to 
6.5M at twenty minutes. At pH 2.5, the peak nitric oxide was 30.7M reached at 5 
minutes and again slowly falling. At pH 3, the rise in nitric oxide concentration was very 
slow but continuous, reaching a peak of 11.9M at the end of the experiment (Figure 
3.7B). The changes in oxygen concentration with the ascorbic acid 500M again reflected 
the changes in nitric oxide at the different pH with the most marked and rapid fall in 
oxygen being seen at pH 1.5. Interestingly, the rise in oxygen concentration in the latter 
part of the experiment was most marked also with the pH 1.5 solutions (Figure 3.8B).   
With ascorbic acid 2000M the rate of rise in nitric oxide was closely related to the pH 
being most rapid at pH 1.5 and slowest at pH 3. At each pH, the final concentration 
obtained was approximately 70M, though the plateau did seem to be slightly lower in the Chapter 3    69 
lowest pH solutions (Figure 3.7C). The change in oxygen concentration again reflected the 
rise in nitric oxide being most rapid at pH 1.5 and slowest at pH 3. In addition, at pH 3 
there seemed to be some residual oxygen present (Figure3.8C). 
(A)
 
(B)
 
(C)
 
Figure 3.7: Nitric oxide levels (µM) in the simulated gastric juice (NaSCN, aerobic condition) of 
different pH values pH 1.5 (squares), 2.5 (triangles) and 3.0 (circles), following nitrite addition 
(100µM) at t=10 min, in the presence of ascorbic acid 100µM (A), 500µM (B) or 2000µM (C). Values 
are presented as mean of two experiments. Chapter 3    70 
(A)
 
(B)
 
(C)
 
Figure 3.8: Dissolved oxygen levels (%) in the simulated gastric juice (NaSCN, under aerobic 
condition) of different pH values pH 1.5 (squares), 2.5 (triangles) and 3.0 (circles) on, following nitrite 
addition (100µM) at t=10 min, in the presence of ascorbic acid 100µM (A), 500µM (B) or 2000µM (C). 
Values are presented as mean of two experiments. 
 Chapter 3    71 
3.3.2  Discussion 
The effect of pH on nitric oxide and oxygen were similar at the ascorbic acid 100M and 
ascorbic acid 500M experiments. However, the changes are clearer in the ascorbic acid 
500M experiment and therefore discussion will focus on that experiment. With the 
ascorbic acid 500M the rise in nitric oxide was most rapid and greatest at pH 1.5 and 
slowest at pH 3. This can be explained by the effect of the pH on the proportion of 
nitrosating species present with a high affinity for reacting with ascorbic acid. The 
concentration of NO
+
 in the solution of nitrite is inversely related to the pH value being 
greatest at lowest pH 
(50, 104). The reactive nitrosating species in the presence of thiocyanate 
is thought to be NOSCN, which is formed by a reaction between NO
+
  and SCN
-. 
Consequently, lowering the pH will increase the concentration of NOSCN and thus 
increase the rate of reaction of ascorbic acid and the rate of formation of nitric oxide. The 
initial fall in the oxygen concentration was also greatest at lowest pH, again being 
consistent with the fall in oxygen being directly related to the concentration of nitric oxide 
which will then react with the oxygen to form nitrosating species again 
(50, 104, 120). 
In the ascorbic acid 500M experiment the fall in nitric oxide concentration following its 
peak was more marked at pH 1.5 than at pH 2.5 and this was reflected in a more rapid rise 
in oxygen following its nadir at pH 1.5 than at pH 2.5. This is likely to be related to the 
fact that at pH 1.5 the more rapid recycling will result in the complete depletion of ascorbic 
acid whereas at pH 2.5 the slower chemistry results in a slower rate of recycling and thus 
some ascorbic acid will remain 
(104). Though ascorbic acid was not measured in this 
particular experiment, the results from earlier experiments indicate that at pH 1.5 in the 
presence of thiocyanate, ascorbic acid would be fully depleted. Chapter 3    72 
In the 500M experiment at pH 3 the rise in nitric oxide concentration was very slow but 
at the end of the experiment it was higher than at the lower pHs where nitric oxide 
concentration had fallen back to almost zero. In this experiment the slow rate of production 
of nitric oxide results in very slow recycling and thus ascorbic acid remains. In the 
presence of adequate ascorbic acid equilibrium will therefore be produced between the 
production of nitric oxide by the reaction in nitrosating species and ascorbic acid and the 
loss of nitric oxide due to the reaction of nitric oxide with the oxygen. The latter reaction 
will be very slow at this low concentration of nitric oxide.  
With the ascorbic acid 2000M, the rise in nitric oxide was most rapid with the pH 1.5 
solution and slowest with the pH 3 solution. In each case, the final concentration achieved 
at the end of the experiment was fairly similar at approximately 70M and it seemed to be 
slightly lower with the lowest pH. The fall in oxygen concentration again reflected the rise 
in nitric oxide. In this experiment the ascorbic acid being in gross excess will not be rate-
controlling and therefore one can see the clear effects of the pH on the rate of production 
of nitric oxide. Again the slightly lower plateau with nitric oxide at pH 1.5 may be 
explained by the more rapid recycling at this pH and thus greater conversion of the 
nitrosating species to nitrate which can no longer be converted to nitric oxide. Chapter 3    73 
3.4  Nitrite chemistry in the simulated gastric juice: effect of oxygen  
3.4.1  Nitric oxide levels following nitrite addition in theabsence of ascorbic 
acid  
The addition of nitrite (100µM) to the simulated gastric juice (with NaSCN, pH 1.5) in 
absence of ascorbic acid under both aerobic and anaerobic conditions produced very 
limited amount of nitric oxide were, 0.34µM and 2.25µM, respectively. 
3.4.2  Nitric oxide and dissolved oxygen levels following nitrite addition in 
presence different concentration of ascorbic acid 
The presence of oxygen had a profound effect on the rise in nitric oxide when nitrite 
100M was added to HCl pH 1.5 containing thiocyanate and this was most marked at the 
lowest ascorbic acid concentration. 
With ascorbic acid 100M in the presence of oxygen, the peak nitric oxide concentration 
was 17.4µM occurring one minute after the addition of nitrite and then it slowly fell during 
the experiment. In contrast, in the absence of oxygen a peak nitric concentration of 78µM 
occurred one-two minutes after adding nitrite and this only showed a slight fall throughout 
the remainder of the experiment (Figure 3.9A).  
With the ascorbic acid 500M and ascorbic acid 2000M, the rises in the nitric oxide level 
under the anaerobic conditions were similar to that seen with ascorbic acid100M. 
However, under aerobic conditions the rise in nitric oxide concentration was greater with 
the ascorbic acid 500M reaching a peak of 68M at five minutes and then falling to 
undetectable levels at the end of the experiment (Figure 3.9B). With the ascorbic acid Chapter 3    74 
2000M, the rise in nitric oxide under the aerobic conditions reached a peak of 63M at 
ten minutes and remained elevated throughout the experiment (Figure 3.9C).  
(A)
 
(B)
 
(C)
 
Figure 3.9: Nitric oxide levels (µM) in the simulated gastric juice (NaSCN, pH 1.5) under aerobic 
(squares) and anaerobic (triangles), conditions, following nitrite addition (100µM) at t=10min, in the 
presence of ascorbic acid 100µM (A), 500µM (B) or 2000µM (C). Values are presented as mean of two 
experiments. 
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3.4.3   Ascorbic acid measurements 
The presence of oxygen had a marked effect on the amount of ascorbic acid consumed 
during the experiment. In the absence of oxygen ascorbic acid remained present at the end 
of each experiment even when only ascorbic acid 100M had been added. In contrast, in 
the presence of oxygen all the ascorbic acid was consumed during the experiment at 
100M and more than 90% with the ascorbic acid 500M but only 32% with the ascorbic 
acid 2000M (Table 3.3). 
Table 3.3: Ascorbic acid consumed (%) in the simulated gastric juice (NaSCN, pH 1.5), following 
nitrite addition (100µM) in the presence of ascorbic acid 100µM, 500µM or 2000µM over 60 minutes 
incubation, under both aerobic and anaerobic conditions. Values are presented as mean of two 
experiments.  
 
 [AA]µM 
at t=0  
AA consumed (%) with  
 oxygen at t= 70 min 
AA consumed (%) without   
oxygen at t= 70 min  P Value 
100  99.18   72.13  P < 0.05 
500 91.47    48.89 
 
2000 32.05    10.12 
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3.4.4  Discussion 
These experiments show the dramatic effect that the presence of oxygen has on this 
chemistry. With ascorbic acid 100M in the presence of oxygen, the peak nitric oxide 
concentration was only 17.4µM and then rapidly fell whereas in the absence of oxygen the 
nitric oxide concentration reached a peak value of 78µM and remained elevated throughout 
the experiment. Consequently, the area under the nitric oxide time curve was of the order 
of 20 times greater in the absence than in the presence of oxygen. As shown in earlier 
experiments, the key reaction in producing the nitric oxide in the acidified nitrite solution 
is the presence of ascorbic acid. The much lower nitric oxide concentration in the ascorbic 
acid 100M experiment in the presence of oxygen can be explained by the rapid 
consumption and depletion of ascorbic acid 
(50, 104). This is consistent with the fact that no 
ascorbic acid was detectible at the end of the experiment. Stoichiometrically, one molecule 
of ascorbic acid should convert one molecule of nitrite in acidic conditions to one molecule 
of nitric oxide. This chemistry was apparent in the absence of oxygen where nitrite 100M 
produced 80M nitric oxide. However, in the presence of oxygen the nitric oxide formed 
in this way rapidly reacted with the oxygen to reform nitrosating species which can further 
react with the ascorbic acid and they converted that to nitric oxide. However, these 
recycling results in the rapid consumption of ascorbic acid and consequently the nitrosating 
species formed cannot be converted back into nitric oxide. The rapid rate of this recycling 
appears as 1.5 in the presence of thiocyanate and is demonstrated by the fact that ascorbic 
acid must be consumed within a minute of adding the nitrite, as the nitric oxide 
concentration was markedly lower at this time point which represents its concentration in 
the presence of oxygen. 
In the anaerobic experiments increasing the ascorbic acid concentration to 500M or 
2000M had no significant effect on the nitric oxide response. This can be explained by Chapter 3    77 
the fact that adequate ascorbic acid was available even at its lowest concentration and 
therefore increasing the concentration had little effect on the nitric oxide profile. In 
contrast, in the presence of oxygen increasing the ascorbic acid concentration markedly 
changed the nitric oxide profile and at the ascorbic acid 2000M concentration the nitric 
oxide profile became very similar to that in the absence of oxygen. The latter can be 
explained by the fact that at high concentrations of ascorbic acid the recycling of the nitrite 
results in depletion of oxygen (see earlier experiment 3.1.2) and consequently the 
experiment then becomes an anaerobic experiment. In the absence of oxygen, the nitric 
oxide formed remains as nitric oxide as it cannot react with oxygen to return to nitrosating 
species and nitrite.   
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3.5  Nitrite chemistry in the simulated gastric juice: effect of different 
concentrations of dietary phenolics in the presence of oxygen 
3.5.1  At low concentration (250M) 
3.5.1.1  Nitric oxide and dissolved oxygen levels following nitrite addition in the 
presence of caffeic acid (CA), ferulic acid (FA), chlorogenic acid (CGA) and 
gallic acid (GA) individually in comparison with ascorbic acid  
In the presence of oxygen the addition of nitrite 100µM to the simulated gastric juice 
containing NaSCN (1mM) and AA or a range of dietary phenolics (FA, CA, GA and CGA, 
250µM) individually at pH 1.5, resulted in nitric oxide production and a fall in oxygen 
concentrations (Figure 3.10 and 3.11). With ferulic and caffeic acid (250µM), the nitric 
oxide concentration reached a peak value of 3.5µM and 5.6µM respectively two minutes 
after addition of nitrite. These nitric oxide concentrations then slowly decreased to 
undetectable level by the end of the experiment. With gallic acid (250µM) the nitric oxide 
reached a plateau at 7.8µM and remained at that level between two and ten minutes after 
adding the nitrite. The nitric oxide concentration then slowly fell to 4µM by the end of the 
incubation time period. With chlorogenic acid (250µM) the nitric oxide rose in a similar 
manner to that observed following gallic acid, reaching a plateau at 6.5µM, although, it 
remained elevated throughout the duration of the experiment. With ascorbic acid (250µM) 
the nitric oxide concentration reached a peak at 23.5µM, occurring at one minute from the 
addition of nitrite. This rise in the nitric oxide was different from that seen after other 
phenolics acids were added. There was a clear rise and then clear fall in the nitric oxide 
concentration (Figure 3.10).   
With ferulic acid or caffeic acid (250µM) the change in nitric oxide concentrations were 
reflected in similar changes in the degree of fall in the oxygen concentration. The oxygen Chapter 3    79 
concentrations were decreased from a baseline value 20% to 19% and 18%, respectively. 
Thereafter the oxygen concentrations remained steady or slightly increased back towards 
the baseline level. The change in oxygen concentration with gallic acid and chlorogenic 
acid (250µM) again reflected the change in nitric oxide with the most marked and rapid 
fall in oxygen being seen with gallic acid. With ascorbic acid (250µM), the marked rise in 
nitric oxide was reflected by a marked fall in the dissolved oxygen concentration with the 
lowest point of oxygen concentration occurring two minutes after the addition of nitrite 
being 14.5% and then slowly increasing and returning to 19% at the end of the experiment 
(Figure 3.11).   
 
Figure 3.10: Effect of presence of 250µM ferulic acid (squares), caffeic acid (triangles), gallic acid 
(open circles), chlorogenic acid (circles) or ascorbic acid (open squares) on nitric oxide levels (µM) in 
the simulated gastric juice, following nitrite addition (100µM) at t=10 min under aerobic conditions. 
Values are presented as mean of two experiments. 
 
Figure 3.11: Effect of presence of 250µM ferulic acid (squares), caffeic acid (triangles), gallic acid 
(open circles), chlorogenic acid (circles) or ascorbic acid (open squares) on dissolved oxygen levels (%) 
in the simulated gastric juice, following nitrite addition (100µM) at t=10 min. Values are presented as 
mean of two experiments. Chapter 3    80 
3.5.2  At high concentration (2000M) 
3.5.2.1    Nitric oxide and dissolved oxygen levels following nitrite addition in the 
presence of caffeic acid (CA), ferulic acid (FA), chlorogenic acid (CGA) and 
gallic acid (GA) individually in parallel with ascorbic acid  
When ferulic acid (2000µM), was present in the system described under 3.5.1.1, it 
produced nitric oxide at a peak value of 5.2µM within minute of the addition of nitrite. 
With caffeic acid (2000µM), the nitric oxide rose in a similar manner to that observed 
following ferulic acid, reaching a value 7.5µM minute after the addition of nitrite. Under 
both conditions the nitric oxide concentrations then slowly decreased to become 
undetectable by the end of incubation time period. With gallic acid (2000µM), the nitric 
oxide concentration peaked at 20µM ten minutes after the addition of nitrite, and then 
slowly decreased to 6µM by the end of the experiment. With chlorogenic acid (2000µM) 
the rise in the nitric oxide concentration gradually reached a peak of 39.5µM at the end of 
the experiment. In the presence of ascorbic acid (2000µM), there was a marked rise in 
nitric oxide, which reached a value 63.1µM approximately ten minutes after the addition of 
nitrite. The nitric oxide concentration remained elevated throughout the duration of the 
experiment (Figure 3.12).    
With ferulic acid (2000µM) the rise in nitric oxide concentration was mirrored by a fall in 
the oxygen concentration from 20% to 19% within the first two minutes, and then it slowly 
decreased to 17% by the end of the experiment. With caffeic acid (2000µM), the dissolved 
oxygen concentration fell from a baseline value of 20% to 19% within the first two 
minutes after the addition of nitrite. Thereafter the oxygen concentration remained steady 
and slightly increased back towards baseline level. With gallic acid (2000µM), the rise in 
nitric oxide was mirrored by the fall in dissolved oxygen concentration with the nadir of 
8% oxygen concentration at fifteen minutes after the addition of nitrite. This then slowly Chapter 3    81 
increased and returned to12% at the end of the experiment. With chlorogenic acid 
(2000µM), the oxygen concentration gradually decreased to become undetectable at 20 
minutes and then slowly increasing to 2% at the end of the experiment. With ascorbic acid 
(2000µM), the oxygen concentration rapidly decreased to become undetectable at first 
three minutes and remained undetectable for the duration of the experiment (Figure 3.13).  
 
Figure 3.12: Effect of presence of 2000µM ferulic acid (squares), caffeic acid (triangles), gallic acid 
(open circles), chlorogenic acid (circles) or ascorbic acid (open squares) on nitric oxide levels (µM) in 
the simulated gastric juice, following nitrite addition (100µM) at t=10 min under aerobic conditions. 
Values are presented as mean of two experiments. 
 
Figure 3.13: Effect of presence of 2000µM ferulic acid (squares), caffeic acid (triangles), gallic acid 
(open circles), chlorogenic acid (circles) or ascorbic acid (open squares) on dissolved oxygen levels (%) 
in the simulated gastric juice, following nitrite addition (100µM) at t=10 min. Values are presented as 
mean of two experiments. Chapter 3    82 
3.6  Nitrite chemistry in the simulated gastric juice: effect of different 
concentrations of dietary phenolics in the absence of oxygen 
3.6.1   Nitric oxide levels following nitrite addition in the presence of caffeic 
acid (CA), ferulic acid (FA), chlorogenic acid (CGA) and gallic acid (GA) 
individually, in compare with ascorbic acid  
3.6.1.1  At low concentration (250M) 
In the absence of oxygen the addition of nitrite 100µM to simulated gastric juice (with 
NaSCN, pH 1.5 ) containing ferulic acid (250µM) produced nitric oxide reaching a peak 
value of 10µM at three minutes after the addition of nitrite. The nitric oxide concentration 
then slowly decreased to 2µM by the end of the incubation time period. With caffeic acid 
(250µM) the nitric oxide concentration peaked at 18.4µM two minutes after the addition of 
nitrite and then slowly decreased to 2.5µM by the end of the experiment. With the 
chlorogenic acid (250µM) the rise in nitric oxide concentration was gradual but 
continuous, reaching a peak of 36.4µM by the end of the experiment. With gallic acid 
(250µM) there was a marked rise in nitric oxide reaching a peak of 50µM at twenty five 
minutes and then slowly fall to 40.7µM by the end of the experiment. With ascorbic acid 
(250µM) there was a clear rise in the nitric oxide concentration reaching a peak value of 
89.5µM minute after the addition of nitrite. The nitric oxide then slowly decreased to 
58µM by the end of the incubation time (Figure 3.14). 
3.6.1.2  At high concentration (2000M) 
In the absence of oxygen, the rise in the nitric oxide profile after adding nitrite (100µM) to 
simulated gastric juice (with  NaSCN, pH 1.5) was similar in the presence of ferulic or 
caffeic acid (2000µM). With ferulic acid (2000µM) the nitric oxide concentration reached Chapter 3    83 
a peak value of 17.5µM minute after the addition of nitrite and then slowly decreased to 
2.2µM at seventy minutes. With caffeic acid (2000µM) the nitric oxide rose in a similar 
manner to that observed following ferulic acid, reaching a value approximately 15µM 
higher than that obtained with ferulic acid (2000µM). With chlorogenic (2000µM) the rise 
in nitric oxide concentration gradually reached a plateau at a level of 54µM occurring at 
ten minutes from adding nitrite. The nitric oxide concentration remained elevated 
throughout the duration of the experiment. With gallic acid or ascorbic acid (2000µM), the 
addition of nitrite it produced high peak nitric oxide concentration occurred approximately 
ten minutes after the addition of nitrite. With gallic acid, the nitric oxide peak value was 
80µM and then this gradually decreased to 46µM by the end of the incubation time period. 
With ascorbic acid, the nitric oxide peak was approximately 15µM lower than that 
observed with gallic acid and by the end of experiment it was 49µM (Figure 3.15).   
 
Figure 3.14: Nitric oxide levels (µM) in the simulated gastric juice, following nitrite addition (100µM) 
at t=10 min, in presence 250µM of ferulic acid (squares), caffeic acid (triangles), gallic acid (open 
circles), chlorogenic acid (circles) or ascorbic acid (open squares) under anaerobic conditions. Values 
are presented as mean of two experiments. 
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Figure 3.15: Nitric oxide levels (µM) in the simulated gastric juice, following nitrite addition (100µM) 
at t=10 min, in presence 2000µM of ferulic acid (squares), caffeic acid (triangles), gallic acid (open 
circles), (circles) or ascorbic acid (open squares) under anaerobic condition. Values are presented as 
mean of two experiments. 
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3.6.2  Discussion 
The second aim of this study was to compare the ability of common dietary antioxidants, 
belonging to the phenolics, with that of ascorbic acid at reducing nitrite to nitric oxide 
under conditions simulating those occurring in the upper gastrointestinal tract. Four 
phenolic acids were tested alongside ascorbic acid in two different concentrations: caffeic 
acid, ferulic acid, chlorogenic acid, and gallic acid. Phenolic acids occur in most fruits, 
vegetables, and dicotylenous plants either in free or conjugated form. Caffeic and ferulic 
acids are hydroxycinnamates occurring in fruits and vegetables; chlorogenic acid, an ester 
of caffeic acid and quinic acid, is abundant in coffee and apples; meanwhile, gallic acid is a 
major building block in the synthesis of tannins, which are abundant and confer their 
astringent properties to tea and red wines 
(130, 131). Ascorbic acid, which is actively secreted 
in the stomach, is a major inhibitor of acid catalysed nitrosation in the lumen 
(148-150). 
Meanwhile, the potential chemo-protective effect of phenolic compounds against 
nitrosative stress has been highlighted in the past 
(151-153). Previous studies investigated the 
nitrosation inhibiting potential of dietary phenolics in single-phase systems, based on their 
nitric oxide promoting abilities 
(154, 155). However, recent studies have demonstrated that 
high nitric oxide production in the presence of lipids is the main cause for the transfer of 
the nitrosative stress from the aqueous to the lipid compartment, an issue relevant to 
transfer of nitrosation to the gastric epithelium 
(156). 
The present experiments compared the nitric oxide generating abilities of the four phenolic 
acids with ascorbic acid. The addition of nitrite (100µM) to the simulated gastric juice 
containing 1mM NaSCN and low concentration ascorbic acid (250µM) caused a rapid rise 
in nitric oxide to 23M followed by a fall in nitric oxide accompanied by an initial fall in 
oxygen. At high concentration ascorbic acid (2000µM) increased nitric oxide to 63M 
which was maintained and accompanied by the complete depletion of oxygen. When the Chapter 3    86 
low dose ascorbic acid experiment was repeated under anaerobic conditions, the nitric 
oxide reached 89.5M and was maintained at this level. The rapid rise and then fall of 
nitric oxide with low dose ascorbic acid in the presence of oxygen can be explained by the 
rapid depletion of ascorbic acid due to the nitric oxide reacting with oxygen to re-form 
nitrosating species, which can react again with the remaining ascorbic acid as shown in 
Scheme 3.3. This recycling has been shown to lead to the rapid depletion of ascorbic acid 
under aerobic conditions 
(157, 158). The reaction between nitric oxide and oxygen is second 
order with respect to nitric oxide and the rapid depletion of ascorbic acid can be explained 
by the high concentrations of nitric oxide initially produced by the ascorbic acid 
(159, 160). 
When the experiment was performed in the presence of low concentration gallic acid and 
chlorogenic acid, it produced a slower and less marked initial rise in nitric oxide than 
ascorbic acid (i.e. longer lasting than a burst); however, the nitric oxide level was 
maintained and there was a less marked early depletion of oxygen. When the low dose 
gallic acid and chlorogenic acid experiment was repeated under anaerobic conditions, the 
final concentration obtained was lower in both cases than with the ascorbic acid. The less 
rapid initial rise in nitric oxide suggests that these phenolic acids have a lower affinity for 
the nitrosating species than ascorbic acid under similar experimental conditions. Previous 
studies proposed that the nitric oxide-promoting ability of chlorogenic acid is related to the 
presence of the catechol group, enabling formation of nitric oxide upon encounter with 
nitrous acid, and leading to the formation of an intermediate o-semiquinone radical able to 
then react with nitrogen dioxide to generate a nitrated polyphenol end-product, this 
depleting the system in nitrosating species and limiting further nitric oxide formation 
scheme 3.3 
(155).  
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Scheme 3.3: proposed mechanism of nitric oxide release from acidified nitrite in presence of ascorbic 
acid (left) and chlorogenic acid (right).
(147). 
 
Ferulic acid and caffeic acid produced a different response with respect to both nitric oxide 
and oxygen than the other antioxidants tested. At both low and high concentrations they 
produced a rapid but limited rise in nitric oxide to 5M at low concentration and 7.5M at 
high concentration, followed by a rapid fall and in both cases with little discernable change 
in oxygen concentration. In the absence of oxygen the initial rise in nitric oxide was higher 
(35M) but was again followed by a rapid fall with similar pattern with both low and high 
concentrations. The nitric oxide response observed with caffeic acid and ferulic acid 
suggests that the nitrite are reduced to nitric oxide but that a subsequent reaction then 
occurs leading to a fall in nitric oxide. It has been demonstrated that both ferulic and 
caffeic acids can form nitroso-derivatives upon encounter with acidified nitrite, via 
preferential reaction between their side chain and the nitrosating species, with limited or no 
nitric oxide production 
(161-164). This mechanism is key in ensuring the efficient, stable 
scavenging of nitrosating species, without generating nitric oxide. According to Peri et 
al.(2005) the limited nitric oxide production by ferulic acid is linked to the absence of a 
catechol group, preventing the formation of an o-semiquinone radical to react with Chapter 3    88 
nitrogen dioxide 
(155). However, this research indicates, however, that the nitric oxide 
promoting ability of caffeic acid was similar to that of ferulic acid, despite the fact that 
caffeic acid possesses a catechol group. It is therefore likely that the nitric oxide promoting 
abilities of phenolic acids may not be entirely based on the presence or lack of a catechol 
group. 
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General conclusion 
Over the last fifty years there has been concern about luminal nitrite as a risk factor for 
upper gastro-intestinal malignancies 
(49, 78). This has arisen from evidence that salivary 
nitrite generates nitrosating species and nitric oxide when encountering acidic gastric juice 
(49, 78, 100).  
Therefore it was important to study the influence of ascorbic acid, sodium thiocyanate, 
oxygen, and pH on nitrite chemistry in the simulated GOJ environment. It was also 
relevant to investigate the effect of other dietary antioxidants such as ferulic acid, caffeic 
acid, gallic acid, and chlorogenic acid on the nitrite chemistry under conditions simulating 
the lumen at the GOJ.  
Previous studies both in the simulated bench-top system and in situ have examined the fate 
of salivary nitrite when it encounters acidic gastric juice 
(48, 103, 104). This study, in 
accordance with the literature, has demonstrated that nitrite in the simulated GOJ 
environment is rapidly converted to nitric oxide in the presence of ascorbic acid 
(50, 53, 
104).This is due to fact that only a very limited amount of nitric oxide is produced in the 
absence of ascorbic acid. Thus ascorbic acid is effectively reducing the nitrosating species 
to nitric oxide and in the process is oxidized to dehydroascorbic acid. However, the 
presence of oxygen reduces the efficacy of ascorbic acid because nitric oxide can react 
with dissolved oxygen to reform nitrosating species. The recycling of nitric oxide means 
more ascorbic acid is consumed and this was clearly observed in this study. We also 
observed that ascorbic acid at low or medium concentrations is an important controlling 
factor for the recycling processes, while with higher concentrations of ascorbic acid 
dissolved oxygen in the system was the main factor controlling the recycling pathway. 
These findings further support previous observations that nitric oxide recycling is 
maintained until either the ascorbic acid or oxygen is depleted 
(104). Chapter 4  91
The present study also demonstrated that the pH of the simulated gastric juice had a clear 
effect on the rate of nitric oxide production in the presence of ascorbic acid. The nitric 
oxide concentration in a solution of nitrite containing ascorbic acid is inversely related to 
the pH, being greatest at the lowest pH of 1.5. The presence of sodium thiocyanate in the 
simulated gastric juice also enhances the conversion of nitrite to nitric oxide and increases 
the ascorbic acid consumption. Moreover, the absence of oxygen in the system markedly 
increases nitric oxide concentration and also resulted in ascorbic acid being present 
throughout the experiment.  
This study has demonstrated a different pattern of nitric oxide production from acidified 
nitrite in the presence of a range of dietary phenolics concentrations compared with 
ascorbic acid under conditions simulating the GOJ. Ferulic and caffeic acids produced only 
a small increase in nitric oxide, which was not sustained under both aerobic and anaerobic 
conditions. However, unlike ferulic and caffeic acids, gallic and chlorogenic acids 
produced a much more marked rise in nitric oxide which remained elevated under both 
aerobic and anaerobic conditions. In contrast, ascorbic acid produced a strong increase in 
nitric oxide production, which was followed by a clear fall under aerobic conditions. 
However, with high concentration of ascorbic acid and under anaerobic conditions, nitric 
oxide was sustained throughout the duration of experiment.  
In summary, nitric oxide has numerous potential effects in the mediation of physiological 
and pathological mechanisms. It remains to be seen whether the generation of nitric oxide 
at the GOJ and the factors we have demonstrated to influence this are involved in the high 
incidence of disturbed physiology and pathology occurring at this anatomical site. 
Further studies are required to investigate the biological significance of the nitric oxide 
generated at the GOJ. In addition, it may be important to study the effect of the various 
dietary anti-oxidants in modifying any biological effects.    
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